NewslettersHematopoiesis News Patient- and Physician-Reported Pain after Tyrosine Kinase Inhibitor Discontinuation among Patients with Chronic Myeloid Leukemia By Noshin Noorjahan - November 8, 2022 0 Researchers plotted the trajectory of chronic myeloid leukemia patient-reported pain over time using a piecewise mixed-effects ordinal logistic model after discontinuation of tyrosine kinase inhibitor therapy. [Haematologica] Full Article